Tranexamic acid for treating blood on the brain
Treatments studied
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests whether a medicine called tranexamic acid (which helps blood clot) can help your body reabsorb a subdural hematoma, a type of bleeding on the brain, without needing surgery. If successful, this treatment could reduce the need for surgery and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a chronic subdural hematoma (an older blood collection on the brain) that does not need surgery according to your neurosurgeon.
- You were diagnosed within the last 14 days.
- You are able to take study pills regularly, or a caregiver can help you take them.
- Your kidneys are working well enough (no major kidney disease).
- You have no history of blood clots, seizures, or recent stroke.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether giving a medicine called tranexamic acid (TXA) during surgery helps prevent rebleeding after draining a chronic subdural hematoma. TXA helps stop bleeding, and the goal is to reduce the chance the hematoma comes back.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial tests if a special cold plasma treatment applied during surgery can reduce the chance of a chronic subdural hematoma (a slowly growing blood collection on the brain) from returning. It may help people who already need surgery for this condition.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
This Phase 3 study tests whether tranexamic acid (a medicine that helps blood clot) can stop a chronic subdural hematoma from getting worse. It’s for people diagnosed by CT who are being treated without surgery at first.
This trial studies whether tranexamic acid (a medicine that helps slow blood breakdown) can improve outcomes for people with symptomatic subdural hematoma—blood collecting between the brain and its outer covering. You may be able to join if you’re older, have bleeding seen on CT, symptoms linked to the bleed, and meet several safety and timing rules.
Hear when a new Chronic Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.